deferiprone
Showing 1 - 24 of 24
Pantothenate Kinase-Associated Neurodegeneration Trial (Deferiprone)
No longer available
- Pantothenate Kinase-Associated Neurodegeneration
- Deferiprone
- (no location specified)
Nov 9, 2022
Amyotrophic Lateral Sclerosis Trial in France (Deferiprone, Placebo Oral Tablet)
Active, not recruiting
- Amyotrophic Lateral Sclerosis
- Deferiprone
- Placebo Oral Tablet
-
Angers, France
- +14 more
Nov 4, 2022
Chronic Iron Overload Trial in Worldwide (Deferiprone, Deferasirox)
Acute Kidney Injury Trial (deferiprone, Placebo)
Withdrawn
- Acute Kidney Injury
- deferiprone
- Placebo
- (no location specified)
Aug 20, 2020
Iron Overload, Sickle Cell Disease, Other Anemias Trial in Worldwide (Deferiprone, Deferoxamine)
Parkinson Disease Trial in Worldwide (Deferiprone, Placebo)
Active, not recruiting
- Parkinson Disease
- Deferiprone
- Placebo
-
Innsbruck, Austria
- +24 more
Mar 9, 2021
Parkinson's Disease, Amyotrophic Lateral Sclerosis, Oxidative Stress Trial in Lille (deferiprone, )
Completed
- Parkinson's Disease
- +3 more
- deferiprone
- placebo
-
Lille, FranceHôpital Roger Salengro, CHRU de Lille
Mar 25, 2020
Parkinson's Disease Trial in Worldwide (Deferiprone, Placebo)
Completed
- Parkinson's Disease
- Deferiprone
- Placebo
-
Toronto, Ontario, Canada
- +19 more
Nov 14, 2019
Myelodysplastic Syndrome With Low-grade Lesions, Iron Overload Due to Repeated Red Blood Cell Transfusions Trial in Tel Hashomer
Completed
- Myelodysplastic Syndrome With Low-grade Lesions
- Iron Overload Due to Repeated Red Blood Cell Transfusions
- Deferiprone
-
Tel Hashomer, IsraelChim Sheba Medical Center
Oct 30, 2018
Iron Overload, Sickle Cell Disease, Other Anemias Trial in Worldwide (Deferiprone)
Unknown status
- Iron Overload
- +2 more
- Deferiprone
-
Oakland, California
- +12 more
Jan 10, 2019
Mild Cognitive Impairment Trial in San Antonio (Deferiprone, Placebo phase)
Withdrawn
- Mild Cognitive Impairment
- Deferiprone
- Placebo phase
-
San Antonio, TexasUniversity of Texas Health Science Center
Feb 5, 2018
ALS (Amyotrophic Lateral Sclerosis), Iron Overload Trial in Lille (Deferiprone)
Completed
- ALS (Amyotrophic Lateral Sclerosis)
- Iron Overload
- Deferiprone
-
Lille, FranceHôpital Roger Salengro, CHRU de Lille
Mar 8, 2017
Diabetes, Iron Metabolism Disorders, Gastroduodenal Ulcer Trial in Jerusalem (Deferiprone, Acetylcysteine, Sitagliptin and
Unknown status
- Diabetes Mellitus
- +5 more
- Deferiprone
- +2 more
-
Jerusalem, IsraelHadassah medical center
Aug 24, 2016
Healthy Volunteers Trial in Mont-Royal (Deferiprone, Placebo)
Completed
- Healthy Volunteers
- Deferiprone
- Placebo
-
Mont-Royal, Quebec, CanadaAlgorithme Pharma Inc.
Dec 4, 2014
Prolonged QTc Interval Trial in Tempe (Deferiprone, deferiprone matching tablets, moxifloxacin)
Completed
- Prolonged QTc Interval
- Deferiprone
- +3 more
-
Tempe, ArizonaCelerion
Nov 7, 2014
Beta Thalassemia Major Trial in Cairo (Deferiprone)
Unknown status
- Beta Thalassemia Major
- Deferiprone
-
Cairo, EgyptPediatric Hematology clinic, Ain Shams University
Jan 13, 2015
HIV Infection Trial in Bloemfontein, (Deferiprone)
Completed
- HIV Infection
- Deferiprone
-
Bloemfontein,, South AfricaPAREXEL International
Jul 14, 2014
Parkinson's Disease Trial in Lille (deferiprone, )
Completed
- Parkinson's Disease
- deferiprone
- placebo
-
Lille, FranceService de Neurologie, Clinique Neurologique, EA 2683, IFR 114
Aug 31, 2012
Iron Overload Trial in Philadelphia (deferiprone)
Approved for marketing
- Iron Overload
- deferiprone
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Feb 8, 2012
Friedreich's Ataxia Trial in Worldwide (, deferiprone)
Completed
- Friedreich's Ataxia
- placebo
- deferiprone
-
Victoria, Australia
- +5 more
May 31, 2010
Beta-Thalassemia Trial in Cagliari (deferiprone)
Unknown status
- Beta-Thalassemia
- deferiprone
-
Cagliari, Sardinia, ItalyOspedale Microcitemico, Via Jenner
Jun 23, 2005